[October 31, 2017; Philadelphia, PA] – Over the past decade, new discoveries about cancer cell growth have enhanced our ability to prevent, diagnose, treat, and manage the disease. Recent breakthroughs, such as immunotherapy, have put scientists at the threshold of radically transforming care and potentially discovering a cure.
The Penn Vet Cancer Center will bring together basic cancer research, clinical trials, and patient care, now dispersed across the School of Veterinary Medicine, into one centralized location at Ryan Hospital. In this revolutionized, synergistic environment and state-of-the-art facility, researchers and clinicians will be able to bring research breakthroughs from laboratories directly to patients faster than ever before.
The two-day, inaugural Cancer Center Symposium will begin with Dr. Cheryl London’s talk, “Of mice, dogs and men: Transforming cancer outcomes through comparative oncology,” on Thursday, November 30, 2017, from 6-7:30pm at Penn Vet’s Hill Pavilion (380 S. University Ave., Philadelphia). Admission to this event is FREE and open to the public, but registration is recommended here.
London, DVM, PhD, is a research professor at both the Tufts School of Veterinary Medicine and the Molecular Research Institute at Tufts Medical Center. She is also an associated faculty professor at the Ohio State University College of Veterinary Medicine (OSU CVM).
She is director of the Clinical Trials Office at the OSU CVM and director of Translational Therapeutics at the Center for Clinical and Translational Sciences at OSU’s College of Medicine. Her research interests center primarily on targeted therapeutics and translational/comparative oncology.
Presentations for the scientific community will take place on Friday, December 1, 2017, at the Hill Pavilion (380 S. University Ave., Philadelphia). Registration is available here.
Speakers include:
- Steven Dow, DVM, PhD, Director, Laboratory for Immune and Regenerative Medicine, Colorado State University
- Andrew Ewald, PhD, Associate Professor, Department of Cell Biology, Johns Hopkins School of Medicine
- Amy Leblanc, DVM, Director, Comparative Oncology Program, National Cancer Institute, NIH
- Jaime Modiano, VMD, PhD, Perlman Professor of Oncology and Comparative Medicine, University of Minnesota College of Veterinary Medicine
- Elaine Ostrander, PhD, Head, Comparative Genetics Section, National Human Genome Research Institute
- Rodney Page, DVM, Director, Flint Animal Cancer Center, Colorado State University
- Robert Vonderheide, MD, DPhil, Hanna Wise Professor in Cancer Research at the Perelman School of Medicine, University of Pennsylvania; Director of the Abramson Cancer Center
- Kristy Weber, MD, Professor and Chief, Orthopaedic Oncology, Perelman School of Medicine, University of Pennsylvania; Director of the Sarcoma Program, Abramson Cancer Center
This event is part of the University of Pennsylvania’s ongoing efforts in support of the One Health Initiative, which is dedicated to improving the lives of all species through the integration of human medicine, veterinary medicine, and environmental science.